Atlas Trials

MT10109L in the Treatment of Glabellar Lines

Clinical trial NCT03795922 · COMPLETED

Trial details

NCT number
NCT03795922
Sponsor
Medy-Tox
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Glabellar Lines
Start date
2018-12-24
Primary completion
2020-03-13
Enrollment
234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.